177 related articles for article (PubMed ID: 38110515)
21. [Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients].
Xu Y; Zhu R; Sun Y; Li X; Ma X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):127-132. PubMed ID: 28625259
[TBL] [Abstract][Full Text] [Related]
22. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
[TBL] [Abstract][Full Text] [Related]
23. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
[TBL] [Abstract][Full Text] [Related]
24. Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited.
Wiedermann CJ
J Thromb Haemost; 2018 Mar; 16(3):455-457. PubMed ID: 29316235
[TBL] [Abstract][Full Text] [Related]
25. Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes.
Wada T; Shiraishi A; Gando S; Kabata D; Yamakawa K; Fujishima S; Saitoh D; Kushimoto S; Ogura H; Abe T; Mayumi T; Otomo Y
Front Immunol; 2022; 13():1026163. PubMed ID: 36569855
[TBL] [Abstract][Full Text] [Related]
26. A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC.
Iba T; Di Nisio M; Thachil J; Wada H; Asakura H; Sato K; Saitoh D
Clin Appl Thromb Hemost; 2018 Apr; 24(3):439-445. PubMed ID: 28747069
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.
Iba T; Gando S; Saitoh D; Ikeda T; Anan H; Oda S; Kitamura N; Mori S; Kotani J; Kuroda Y
Clin Appl Thromb Hemost; 2017 Jul; 23(5):422-428. PubMed ID: 27161759
[TBL] [Abstract][Full Text] [Related]
28. Early Changes in the Sequential Organ Failure Assessment Score Among Patients With Sepsis-Induced Disseminated Intravascular Coagulation.
Mochizuki K; Mori K; Nakamura Y; Uchimido R; Kamijo H; Takeshige K; Nitta K; Imamura H
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):332S-339S. PubMed ID: 30486666
[TBL] [Abstract][Full Text] [Related]
29. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
[TBL] [Abstract][Full Text] [Related]
30. Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation.
Nagafuchi H; Eguchi Y; Ikeda T
Clin Appl Thromb Hemost; 2019; 25():1076029619834350. PubMed ID: 30836769
[TBL] [Abstract][Full Text] [Related]
31. Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis.
Wada T; Yamakawa K; Kabata D; Abe T; Ogura H; Shiraishi A; Saitoh D; Kushimoto S; Fujishima S; Mayumi T; Hifumi T; Shiino Y; Nakada TA; Tarui T; Otomo Y; Okamoto K; Umemura Y; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S; Gando S
Sci Rep; 2022 Jun; 12(1):9304. PubMed ID: 35660774
[TBL] [Abstract][Full Text] [Related]
32. [Prognosis analysis of multi-indicator combined with sequential organ failure assessment in patients with sepsis].
Zhang L; Zhang J; Jin L; Xu H; Zhao X; Yang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Dec; 35(12):1245-1249. PubMed ID: 38149384
[TBL] [Abstract][Full Text] [Related]
33. Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.
Iba T; Di Nisio M; Thachil J; Wada H; Asakura H; Sato K; Kitamura N; Saitoh D
Crit Care; 2016 Sep; 20():287. PubMed ID: 27629997
[TBL] [Abstract][Full Text] [Related]
34. [Predictive value of the maximum aggregation rate of platelet for septic shock and septic shock with disseminated intravascular coagulation].
Cui Q; Sun X; Ma N; Liu Q; Yang H; Sun R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):238-243. PubMed ID: 36916334
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.
Wiedermann CJ; Kaneider NC
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):521-6. PubMed ID: 16988545
[TBL] [Abstract][Full Text] [Related]
36. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis.
Ikeda M; Matsumoto H; Ogura H; Hirose T; Shimizu K; Yamamoto K; Maruyama I; Shimazu T
J Crit Care; 2018 Feb; 43():48-53. PubMed ID: 28843664
[TBL] [Abstract][Full Text] [Related]
37. The Association Between Sequential Organ Failure Assessment Scores and Mortality in Patients With Sepsis During the First Week: The JSEPTIC DIC Study.
Nakashima T; Miyamoto K; Shimokawa T; Kato S; Hayakawa M
J Intensive Care Med; 2020 Jul; 35(7):656-662. PubMed ID: 29764273
[TBL] [Abstract][Full Text] [Related]
38. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.
Yamakawa K; Fujimi S; Mohri T; Matsuda H; Nakamori Y; Hirose T; Tasaki O; Ogura H; Kuwagata Y; Hamasaki T; Shimazu T
Crit Care; 2011; 15(3):R123. PubMed ID: 21569368
[TBL] [Abstract][Full Text] [Related]
39. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
40. Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
Murao A; Kato T; Yamane T; Honda G; Eguchi Y
Clin Appl Thromb Hemost; 2022; 28():10760296221077096. PubMed ID: 35166576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
